رجوع
نطاق اليوم
KWD 43.03
KWD 45.64
نطاق 52 أسبوعًا
KWD 22.71
KWD 49.82
حجم التداول
1,694,715
متوسط 50 يوم / 200 يوم
KWD 45.04
/
KWD 38.36
الإغلاق السابق
KWD 42.30
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -13.8 | 0.3 |
| P/B | 21.3 | 3.0 |
| ROE % | -123.1 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.4 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 55.67
+22.5%
Low: KWD 50.00
High: KWD 60.00
ربحية السهم المستقبلية
-KWD 3.14
الإيرادات المقدّرة
19.72M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.34
KWD 0.51 – KWD 3.20
|
868.85M | 4 |
| FY2029 |
-KWD 0.19
-KWD 0.44 – -KWD 0.07
|
595.21M | 4 |
| FY2028 |
-KWD 1.24
-KWD 2.16 – -KWD 0.20
|
365.31M | 10 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-03 | -KWD 0.88 | -KWD 0.88 | +0.3% |
| 2025-11-14 | -KWD 0.84 | -KWD 0.90 | -7.8% |
| 2025-08-06 | -KWD 0.66 | -KWD 0.98 | -48.5% |
| 2025-05-14 | -KWD 0.63 | -KWD 0.67 | -6.3% |
| 2025-02-27 | -KWD 0.60 | -KWD 0.60 | 0.0% |
| 2024-11-12 | -KWD 0.58 | -KWD 0.66 | -13.8% |
| 2024-08-08 | -KWD 0.61 | -KWD 0.60 | +1.6% |
| 2024-05-07 | -KWD 0.51 | -KWD 0.59 | -15.7% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Debt/Equity of 0.44 — conservative balance sheet
Negative free cash flow of -300.64M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-123.08%
ROIC-81.40%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.44
Current Ratio6.95
Interest Coverage-55.80
التقييم
P/E Ratio
-13.81
Forward P/EN/A
P/B Ratio21.26
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -377.94M |
| ROE | -123.08% | ROA | -93.49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -300.64M |
| ROIC | -81.40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.44 | Current Ratio | 6.95 |
| Interest Coverage | -55.80 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -13.81 | Forward P/E | N/A |
| P/B Ratio | 21.26 | P/S Ratio | N/A |
| PEG Ratio | -0.40 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 1268.74 |
| Forward P/S | 264.63 | Fwd Earnings Yield | N/A |
| FCF Yield | -5.76% | ||
| Market Cap | 5.22B | Enterprise Value | 5.00B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 33.19M | 18.82M |
| Net Income | -377.94M | -246.29M | -165.79M | -134.50M | -131.80M |
| EPS (Diluted) | -3.29 | -2.47 | -1.99 | -2.21 | -3.59 |
| Gross Profit | -1.66M | -1.94M | -2.84M | -89.85M | -89.65M |
| Operating Income | -384.65M | -252.05M | -171.30M | -134.37M | -129.92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 404.27M | 474.92M | 311.04M | 358.17M | 304.45M |
| Total Liabilities | 158.78M | 106.29M | 85.82M | 97.93M | 132.37M |
| Shareholders' Equity | 245.49M | 368.63M | 225.22M | 260.24M | 172.07M |
| Total Debt | 108.92M | 65.13M | 61.82M | 69.40M | 84.47M |
| Cash & Equivalents | 323.53M | 177.88M | 101.86M | 103.28M | 212.84M |
| Current Assets | 385.15M | 451.17M | 288.19M | 328.02M | 265.32M |
| Current Liabilities | 55.42M | 46.94M | 32.74M | 36.39M | 64.30M |
